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Abstract
Single nucleotide polymorphism (SNP) in adiponectin gene has been associated with insulin resistance, diabetes, and cardiovascular disease (CVD).
This study was performed to investigate the association of SNP 276G→T at adiponectin gene with CVD risk factors in Korean type 2 diabetes
mellitus (DM) patients. The subjects were 351 type 2 DM patients visited a DM clinic in Seoul, and the patients with known CVD were excluded.
The adiponectin SNP 276G→T was analyzed and dietary intakes were assessed by a Food Frequency Questionnaire. The prevalence of G/G, G/T,
and T/T genotype was 47.6%, 43.3%, and 9.1%, respectively. Male subjects with T/T genotype showed significantly lower level of adiponectin 
and HDL-cholesterol and significantly higher C-reactive protein (CRP) level compared to G/G and G/T genotypes. In G/G genotype, protein intake 
was negatively correlated to body weight, BMI, and waist circumference, and there were positive correlation between carbohydrate intake and BMI,
waist-hip ratio, and ApoB/apoA-1 ratio in G/T genotype. However, in T/T genotype, there was no significant association between macronutrient
intakes and anthropometric and hematological values. In conclusion, CVD risk would be high in type 2 DM patients with T/T genotype, and the
association of macronutrient intakes with anthropometric and hematologic factors was different among the three adiponectin genotypes. These results
may imply the need for different dietary management regime according to adiponectin genotype to lower CVD complications in Korean type 2
DM patients.
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Introduction18)
Adiponectin is the most abundant adipocyte-secreted hormone 
in blood, and it has been thought to be associated with insulin 
resistance (Kadosaki et al., 2006). Plasma adiponectin levels have 
been reported to be reduced in patients with obesity (Arita et 
al., 1999), type 2 diabetes (Hotta et al., 2000), and coronary 
vascular diseases (CVD) (Hotta et al., 2000), all of which are 
closely related to insulin resistance.  Adiponectin also regulates 
inflammatory response and has an antiatherogenic effect (Ouchi 
et al., 2003). A linkage has been reported between the single 
nucleotide polymorphism (SNP) in adiponectin gene and serum 
adiponectin level and CVD risk factors (Jang et al., 2005; Qi 
et al., 2006). 
Adiponectin gene consists of 3 exons and 2 introns and is 
located on chromosome 3q27 (Bionnet et al., 2000). Many of 
SNPs at adiponectin gene have been shown to be related to 
insulin resistance, type 2 diabetes, and CVD. Among those, 
adiponectin SNP 45T→G in exon 2 and SNP 276G→T in intron 
2 were shown to be associated with type 2 diabetes in a Japanese 
population (Hara et al., 2002), and the SNP 276G→T was 
observed to have a strong association with CVD risk in white 
diabetic patients (Bacci et al., 2004) and in non-diabetic Koreans 
(Jang  et al., 2005).
Dietary factors play an important role in the development of 
type 2 diabetes and CVD. In addition, the expression of gene 
could be modified by environmental factors including diet, and 
the genetic variation may have effect on metabolic response to 
diet (Mutch et al., 2005; Ordovas, 2006). Although the concept 
of personalized nutritional management according to genotype 
was introduced years ago, this time it is early stage of persona-
lized nutrition and much more researches have to be performed 
for the scientific evidence.
The primary goal of this study was to investigate the assoc-
iation of SNP 276G→T at adiponectin gene with CVD risk 
factors in Korean type 2 diabetes mellitus (DM) patients. We 
also examined the association between adiponectin SNP 276G→
T and dietary intakes. 
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Fig. 1. PCR-based Bsm-RFLP analysis of the intron-2 polymorphism of the 
adiponectin gene
Subjects and Methods
Subjects 
The subjects of this study were 351 type 2 DM patients aged 
over 20 years (191 males, 160 females) visited DM clinic in 
Seoul from October 2005 to August 2006. At the first visit, blood 
was drawn after a minimum of 12h fasting, and anthropometric 
parameters and dietary intake were also measured. After the 
examination, only the patients diagnosed as type 2 DM were 
included in this study, and the patients with known CVD 
(myocardial infarction, angina, stroke, and aortic disease) were 
excluded. Written informed consent was obtained from all 
subjects. The protocol was approved by the Institutional Review 
Board of Yonsei University. 
Dietary, anthropometric, and hematological assessment 
Information on food consumption, general characteristics, and 
life-style behavior were obtained by a self-administered questio-
nnaire. Food consumption was assessed using a food frequency 
questionnaire (Oh et al., 2007). Food intake data were analyzed 
using the Can-pro 3.0 software (Korean Nutrition Society, Korea) 
for nutrient analysis to determine nutrient intakes. For anthro-
pometric measurements, body weight, height, and body com-
position were assessed using INBODY 4.0 (Biospace Co. Korea). 
Waist circumferences were measured by a tapeline, and abdo-
minal fat thickness was assessed by ultrasonographic measure-
ment (General Electric logic 7. USA). Body mass index (BMI, 
kg/m
2) was calculated. 
Fasting blood samples were obtained in EDTA-containing 
tubes in the morning and were frozen at -80℃ in aliquots. Fasting 
blood glucose level was measured by Accutrend alpha (Boe-
hringer Mannhin Gmbh, Germany), and hemoglobin A1c level 
was determined using HLC-823 G7 (Tosoh, Japan). Plasma levels 
of total cholesterol, triglyceride and HDL-cholesterol were 
measured using an automatic blood analyzer (COBAS MIRA, 
Switzerland). LDL-cholesterol level was calculated by the for-
mula of Friedwald (Friedwald et al., 1972). Tumor necrosis 
factor-α (TNF-α), interleukin-6 (IL-6), adiponectin (R&D Sys-
tems Inc., USA), and leptin (BioVendor Lab. Med., Czech Repu-
blic) were measured by ELISA Kit. The plasma glucose disapp-
earance rate after intravenous injection of regular insulin (0.1 
U’kg) was determined, and this result of Insulin Tolerance Test 
(KITT  (%/min)) was used as index of insulin resistance.
Genotyping 
Genomic DNA was extracted from heparinized venous blood 
samples using the QIAamp DNA blood mini kit (Quiagen Ltd, 
Crawley, UK). Identification of the polymorphism was carried 
out using PCR (GeneAmp PCR system 9700, Applied Biosys-
tems, USA), followed by a restriction fragment length polymor-
phism (RFLP) assay. The promoter region of the adiponectin 
gene was amplified by polymerase chain-reaction (PCR) using 
the forward primer 5'-GGC CTC TTT CAT CAC AGA CC-3' 
and the reverse primer 5'-AGA TGC AGC AAA GCC AAA 
GT-3'. The PCR products were digested with BsmI (New England 
BioLabs), and the digestion products were resolved by electro-
phoresis in a 3% agarose gel. 
Statistical analysis 
Statistical analysis was conducted using the statistical analysis 
system program (SAS, version 9.1). Data were expressed as the 
mean±standard error. General characteristics and lifestyle beh-
avior were compared by the chi-square test. After the subjects 
were classified into three groups according to SNP 276G→T at 
adiponectin gene, General Linear Model and Duncan’s multiple 
range test were used to analyze between-group differences of 
the mean for all measured parameters. To test the difference 
between two groups, Student’s t-test was used. Pearson’s partial 
correlation coefficient analysis was used to test the association 
between nutrient intake and CVD risk factors according to 
adiponectin genotype. The levels of CRP, TNF-α, IL-6, leptin, 
and adiponectin were transformed to natural log for Duncan’s 
multiple range test and correlation coefficient analysis because 
they were not normally distributed.
Results
Genetic distribution of adiponectin 276 G/T and general 
characteristics of the subjects
A PCR-based BsmI-RFLP analysis was developed as a rapid 
screening method (Figure 1). One hundred sixty seven (47.6%) 
were homozygous for the wild-type allel (G/G), 152 (43.3%) 
were heterozygous (G/T) and only 32 (9.1%) were homozygous 
for the mutation (T/T). The mean age of male and female subjects 
was 54.1 and 58.1 years, and the mean DM duration was 7.23 
years and 8.94 years, respectively. No significant differences in 
age and DM duration among three genotypes were found (Table 
1). Subjects with DM family history were 92 (48.9%) in male 
and 70 (45.2%) in female subjects. About 70.7% of the subjects 
exercised regularly. The proportion of cigarette smokers and So Young Yu et al. 365
Table 1. General characteristics of the subjects according to adiponectin SNP 276G→T 
Male Female 
All (n=191) G/G (n=98)  G/T (n=75)  T/T (n=18)  All (n=160) G/G (n=69)  G/T (n=77)  T/T (n=14) 
Ages 54.1±0.74
1) 53.4±1.09
ns3)  55.8±1.04 51.2±2.54 58.1±0.73 58.3±1.18
ns 58.6±0.97  55.0±2.67 
Duration of DM  7.23±0.56  6.83±0.82
ns  7.29±0.78 9.31±2.63 8.94±0.61 9.24±0.77
ns 8.63±0.96  9.19±2.97 
Family history
  Yes
  No 
 
 92(48.9)
2)
 96(51.1) 
 
 50(51.5)
NS4)
 47(48.5) 
 
34(45.9)
40(54.1) 
 
 8(47.1)
 9(52.9) 
 
 70(45.2)
 85(54.8) 
 
31(46.3)
NS
36(53.7) 
 
30(40.5)
44(59.5) 
 
9(64.3)
5(35.7) 
Cigarette smoking
  Non-smoker
  Ex-smoker
  Current-smoker 
 
 39(23.4)
 82(49.1)
 46(27.5) 
 
 16(19.3)
NS
 45(54.2)
 22(26.5) 
 
21(30.4)
28(40.6)
20(29.0) 
 
 2(13.3)
 9(60.0)
 4(26.7) 
 
129(93.5)
  6(4.3)
  3(2.2) 
 
59(98.3)
NS
 1(1.7)
 0(0.0) 
 
62(91.2)
 4(5.9)
2(2.9) 
 
8(80.0)
1(10.0)
1(10.0) 
Alcohol drinking
  Non-drinker
  Ex-drinker
  Current-drinker 
 
 32(19.1)
 32(19.0)
104(61.9) 
 
 14(16.9)
NS
 15(18.1)
 54(65.0) 
 
15(21.4)
14(20.0)
41(58.6) 
 
 3(20.0)
 3(20.0)
 9(60.0) 
 
 35(24.8)
 81(57.5)
 25(17.7) 
 
19(30.7)
NS
33(53.2)
10(16.1) 
 
14(20.3)
40(58.0)
15(21.7) 
 
2(20.0)
8(80.0)
0(0.0) 
Exercise
  Yes
  No 
 
119(71.7)
 47(28.3) 
 
 54(65.9)
NS
 28(34.1) 
 
51(73.9)
18(26.1) 
 
14(93.3)
 1(6.67) 
 
 99(70.2)
 42(29.8) 
 
42(67.7)
NS
20(36.3) 
 
50(72.5)
19(27.5) 
 
7(70.0)
3(30.0) 
Medication usage,
Yes/No (%)
  Diabetes
  Hypertension Dyslipidemia 
  
66.5/33.5
21.5/78.5
16.7/83.3 
  
62.2/37.8
NS
16.3/83.7
NS
13.3/86.7
NS 
  
76.0/24.0
28.0/72.0
20.0/80.0 
  
50.0/50.0
22.2/77.8
22.2/77.8 
  
76.3/23.7
25.6/74.4
18.1/81.9 
  
78.3/21.7
NS
30.4/69.6
NS
20.3/79.7
NS 
  
74.0/26.0
23.4/76.6
15.6/84.4 
  
78.6/21.4
14.3/85.7
21.4/78.6 
1)  Mean±SE 
2) n  ( % ) 
3)  ns:  not  significant  among  the  three  genotypes  in  the  same  gender  by  Duncan’s  multiple  range  test;  p＜0.05 
4)  NS:  not  significant  among  the  three  genotypes  in  the  same  gender  by  Chi-square  test;  p＜0.05
Table 2. Anthropometric variables of the subjects according to adiponectin SNP 276G→T 
Male Female 
All (n=191) G/G (n=98)  G/T (n=75)  T/T (n=18)  All (n=160) G/G (n=69)  G/T (n=77)  T/T (n=14) 
Weight(kg)   69.7 ± 0.76
1)    68.9 ± 1.09   70.9 ± 1.21   68.7 ± 2.21   59.4 ± 0.74   60.1 ± 1.07   58.4 ± 1.07   61.0 ± 2.96 
BMI(kg/m
2)
2)    24.6 ± 0.21   24.3 ± 0.29   24.9 ± 0.33   24.4 ± 0.73   24.3 ± 0.28   24.6 ± 0.43   23.9 ± 0.38   24.7 ± 1.17 
Waist  (cm)    85.2 ± 0.62   84.2 ± 0.89   86.3 ± 1.01   85.8 ± 1.48   79.7 ± 0.67   80.1 ± 0.96   79.5 ± 0.97   79.4 ± 2.98 
WHR
3)  0.910 ± 0.00 0.905 ± 0.00 0.918 ± 0.01 0.908 ± 0.01 0.911 ± 0.00 0.918 ± 0.01   0.907 ± 0.01  0.898 ± 0.02 
Fatmass(kg)   16.2 ± 0.37   15.9 ± 0.51   17.1 ± 0.61   15.1 ± 0.94   18.7 ± 0.46   19.4 ± 0.71   18.2 ± 0.64   18.7 ± 1.89 
Body  fat(%)    22.6 ± 0.36   22.5 ± 0.47   22.8 ± 0.64   22.3 ± 1.08   30.5 ± 0.47   31.0 ± 0.73   30.2 ± 0.65   29.6 ± 1.69 
AFT(mm)
4)    48.4 ± 1.40   46.1 ± 1.96   50.6 ± 2.38   52.3 ± 2.88   43.7 ± 1.49   43.5 ± 2.19   43.5 ± 2.17   46.0 ± 5.75 
1)  Mean±SE 
2)  BMI:  Body  mass  index 
3)  WHR:  Waist/hip  circumferences  ratio 
4)  AFT:  Abdominal  fat  thickness 
alcohol drinkers were 27.5% and 61.9% of the  male subjects, 
2.2% and 17.7% of the female subjects, respectively.  There were 
no significant differences in drinking, smoking, and exercising 
habits among three groups in both genders. Medication usages 
for diabetes, hypertension, and dyslipidemia were not signi-
ficantly different.
Anthropometric variables according to adiponectin genotype 
As shown in Table 2, mean heights/weights of male and female 
subjects were 168.2 cm/69.7 kg and 156.4 cm/59.4 kg, respe-
ctively. For male and female subjects, BMI values were 24.6 
kg/m
2  and 24.3 kg/m
2, waist circumferences were 85.2 cm and 
79.7 cm, body fat mass were 16.2 kg and 18.7 kg, percentages 
of body fat were 22.6% and 30.5%, and abdominal fat thickness 
were 48.4 mm and 43.7 mm, respectively. In all the measured 
anthropometric variables, significant differences were not found 
among adiponectin genotype groups in both male and female 
subjects. 
Hematological variables according to adiponectin genotype 
Hematological values of the subjects are shown in Table 3. 
Plasma concentrations of insulin, total cholesterol, LDL-choles-
terol, HDL-cholesterol, leptin and adiponectin were significantly 
higher in females than in males (p<0.05), however, no differences 
were found in insulin resistance (KITT), fasting blood glucose, 
hemoglobin A1c, triglyceride, apoB/apoA-1 ratio, CRP, TNF-α 
and IL-6 levels between male and female subjects.
In male subjects, mean values of KITT, fasting blood glucose, 
hemoglobin A1c, and insulin, total cholesterol, LDL-cholesterol, 
and triglyceride were not significantly different among three 366 Adiponectin gene SNP 276G→T and CVD risk
Table 3. Hematological variables of the subjects according to adiponectin SNP 276G→T 
Male Female 
All (n=191) G/G (n=98)  G/T (n=75)  T/T (n=18)  All (n=160) G/G (n=69)  G/T (n=77)  T/T (n=14) 
KITT (%/min)
1)   2.10 ± 0.08
2)   2.14 ± 0.11   2.03 ± 0.12   2.21 ± 0.25   2.18 ± 0.08   2.09 ± 0.12   2.25 ± 0.13   2.21 ± 0.18 
FBS(mg/dl)
3)  162.9 ± 4.19 166.2 ± 6.19 157.2 ± 6.06 169.7 ± 14.7 166.1 ± 4.72 152.7 ± 6.26 176.5 ± 6.80 174.4 ± 22.2 
HbA1c(%)
4)   8.32 ± 0.16   8.42 ± 0.26   8.20 ± 0.22   8.22 ± 0.35   8.53 ± 0.15   8.23 ± 0.23
b5)   8.62 ± 0.20
b   9.51 ± 0.67
a 
Insulin(ng/dl)   7.79 ± 0.29*
6)   7.62 ± 0.43   7.86 ± 0.39   8.44 ± 0.92   8.78 ± 0.35   8.85 ± 0.57   8.54 ± 0.48   9.77 ± 1.11 
T-Chol (mg/dl)
7)  182.6 ± 2.67*  186.0 ± 4.05 180.3 ± 3.88 174.1 ± 7.61 199.1 ± 3.23 198.6 ± 4.51 199.7 ± 4.87 198.5 ± 13.1 
LDL-Chol (mg/dl)
8)  107.6 ± 2.37*  112.5 ± 3.44 103.5 ± 3.69   98.7 ± 6.11 117.9 ± 2.94 115.5 ± 4.25 119.8 ± 4.46 119.9 ± 10.1 
HDL-Chol (mg/dl)
9)  48.5 ± 1.05*  49.0 ± 1.45
a   49.4 ± 1.69
a   42.0 ± 3.18
b   53.6 ± 7.21   54.0 ± 1.99   53.2 ± 1.67   53.6 ± 3.51 
TG (mg/dl)
 10) 132.5 ± 5.47 127.5 ± 7.95 134.6 ± 7.86 151.7 ± 21.5 139.6 ± 7.16 133.2 ± 8.06 147.7 ± 12.5 126.5 ± 19.2 
ApoB/apoA-1
11)   0.85 ± 0.02   0.85 ± 0.03   0.83 ± 0.04   0.92 ± 0.06   0.85 ± 0.03   0.83 ± 0.04   0.87 ± 0.04   0.84 ± 0.09 
CRP(mg/dl)
12)  1.47 ± 0.16   1.19 ± 0.17
b   1.63 ± 0.28
ab   2.50 ± 0.81
a   1.48 ± 0.18   1.26 ± 0.18   1.64 ± 0.30   1.70 ± 0.75 
TNF-α(pg/ml)
 13)  1.29 ± 0.05   1.19 ± 0.06   1.42 ± 0.09   1.22 ± 0.14   1.25 ± 0.06   1.26 ± 0.09   1.26 ± 0.08   1.19 ± 0.17 
IL-6(pg/ml)
14)  1.46 ± 0.13   1.17 ± 0.13   1.84 ± 0.25   1.46 ± 0.51   1.19 ± 0.10   1.04 ± 0.11   1.21 ± 0.13   1.89 ± 0.69 
Leptin(ng/ml)   2.51 ± 0.22*  2.59 ± 0.34   2.61 ± 0.32   1.69 ± 0.25   9.12 ± 0.69   9.87 ± 1.15   8.25 ± 0.90   10.2 ± 2.51 
Adiponectin (μg/ml)   4.05 ± 0.36*  4.21 ± 0.49
a   4.20 ± 0.60
a   2.53 ± 0.63
b   6.81 ± 0.50   6.64 ± 0.71   7.29 ± 0.79   4.96 ± 1.21 
 1 )  K ITT(%/min):  Insulin  tolerance  test  index
 2 )   Mean±SE 
 3 )   FBS:  Fasting  blood  sugar
 4 )   HbA1c:  Hemoglobin  A1c
 5 )   Values  with  different  alphabets  are  significantly  different  among  the  three  genotypes  in  same  gender  by  Duncan’s  multiple  range  test;  p<0.05 
 6 )   *;  significantly  different  between  male  and  female  subjects  by s t u d e n t ’ s  t - t e s t ;  p<0.05
 7 )  T - C h o l :  T o t a l c h o l e s t e r o l
 8 )  L D L - C h o l:  L D L  c h o l e s t e r o l
 9 )  H D L - C h o l :  H D L  c h o l e s t e r o l
10) T G :  T r ig l y c e r id e
11)  Apolipoprotein  B/apolipoprotein  A-1  ratio 
12)  CRP:  C-reactive  protein
13)  TNF-α:  Tumor  necrosis  factor-α
14)  IL-6:  Interleukin-6
Table 4. Hematological variables of the subjects according to KITT index and adiponectin SNP 276G→T
IR NIR
All (n=170) G/G (n=81)  G/T (n=79)  T/T (n=10)  All (n=181) G/G (n=86)  G/T (n=73)  T/T (n=22) 
KITT (%/min)
 1)  1.27 ± 0.03
2)*   1.29 ± 0.05   1.24 ± 0.06   1.28 ± 0.16   2.96 ± 0.06   2.91 ± 0.09
ab   3.11 ± 0.09
a   2.63 ± 0.15
b 
FBS(mg/dl)
 3) 184.7 ± 4.93*
4)  182.9 ± 7.17 183.9 ± 6.94 204.8 ± 26.8 145.3 ± 3.37 139.6 ± 4.43 148.6 ± 5.25 156.7 ± 12.8 
HbA1c(%)
5)  9.01 ± 0.17*  9.01 ± 0.29   9.01 ± 0.21   8.96 ± 0.81   7.84 ± 0.13   7.69 ± 0.19
b   7.76 ± 0.19
b   8.73 ± 0.41
a 
Insulin(ng/dl)   8.91 ± 0.35*  9.06 ± 0.58   8.69 ± 0.43   9.40 ± 1.09   7.59 ± 0.28   7.23 ± 0.38   7.66 ± 0.45   8.87 ± 0.92 
T-Chol (mg/dl)
6) 194.0 ± 3.24*  197.3 ± 4.35 192.2 ± 4.99 183.3 ± 45.6 186.5 ± 2.73 185.6 ± 4.20 187.9 ± 3.96 185.4 ± 8.27 
LDL-Chol (mg/dl)
 7) 113.3 ± 2.96 117.2 ± 4.04 110.8 ± 1.63 102.7 ± 11.2 111.3 ± 2.37 110.8 ± 3.52 112.3 ± 3.65 110.4 ± 6.92 
HDL-Chol (mg/dl)
 8)  48.6 ± 1.21   48.7 ± 1.90
a9)  49.9 ± 1.63
a   38.0 ± 3.67
b   52.9 ± 1.04   53.4 ± 1.44   52.8 ± 1.75   51.2 ± 2.94 
TG (mg/dl)
 10) 161.5 ± 7.36 155.9 ± 9.25
b 160.5 ± 11.9
b 214.7 ± 32.3
a  111.7 ± 4.42 105.9 ± 5.87 120.4 ± 8.10 104.9 ± 7.23 
ApoB/apoA-1
11)  0.91 ± 0.03*  0.91 ± 0.04   0.90 ± 0.04   1.00 ± 0.12   0.79 ± 0.02   0.78 ± 0.03   0.79 ± 0.03   0.82 ± 0.05 
CRP(mg/dl)
 12)  1.68 ± 0.19
2)   1.39 ± 0.23   1.96 ± 0.34   1.88 ± 0.63   1.28 ± 0.13   1.06 ± 0.11   1.30 ± 0.22   2.36 ± 0.81 
TNF-α(pg/ml)
 13)  1.39 ± 0.06*  1.33 ± 0.09   1.42 ± 0.08   1.67 ± 0.26   1.16 ± 0.05   1.12 ± 0.06   1.25 ± 0.10   0.99 ± 0.07 
IL-6(pg/ml)
 14)  1.54 ± 0.14*  1.13 ± 0.12   1.86 ± 0.23   2.11 ± 0.81   1.17 ± 0.10   1.11 ± 0.13   1.16 ± 0.14   1.45 ± 0.48 
Leptin(ng/ml)   5.69 ± 0.56   6.01 ± 0.84   5.58 ± 0.82   3.97 ± 1.75   5.36 ± 0.52   5.16 ± 0.81   5.38 ± 0.69   6.08 ± 1.76 
Adiponectin (μg/ml)   5.15 ± 0.45  5.16 ± 0.62
a   5.42 ± 0.71
a   2.87 ± 0.99
b   5.48 ± 0.43   5.25 ± 0.58
ab   6.17 ± 0.76
a   3.98 ± 0.88
b 
 1 )  K ITT(%/min):  Insulin  tolerance  test  index
 2 )   Mean±SE 
 3 )   FBS:  Fasting  blood  sugar
 4 )   *;  significantly  different  between  male  and  female  subjects  by s t u d e n t ’ s  t - t e s t ;  p<0.05
 5 )   HbA1c:  Hemoglobin  A1c
 6 )  T - C h o l :  T o t a l c h o l e s t e r o l
 7 )  L D L - C h o l:  L D L  c h o l e s t e r o l
 8 )  H D L - C h o l :  H D L  c h o l e s t e r o l
 9 )   Values  with  different  alphabets  are  significantly  different  among  the  three  genotypes  in  same  gender  by  Duncan’s  multiple  range  test;  p<0.05 
10) T G :  T r ig l y c e r id e
11)  Apolipoprotein  B/apolipoprotein  A-1  ratio 
12)  CRP:  C-reactive  protein
13)  TNF-α:  Tumor  necrosis  factor-α
14)  IL-6:  Interleukin-6So Young Yu et al. 367
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Fig. 2. Serum adiponectin concentration according to adiponectin genotype in the each subgroups of median of BMI, fasting blood sugar, triglyceride, and TNF-α 
genotype groups. On the other hand, male subjects with T/T 
genotype showed significantly lower levels of HDL-cholesterol 
and adiponectin and higher CRP compared to other genotypes 
(p<0.05).
In female subjects, mean values of fasting blood glucose, and 
insulin, plasma lipids, and immune variables were not significan-
tly different. However, hemoglobin A1c level was significantly 
higher in T/T genotype than other two genotypes (p<0.05).
Hematological variables according to KITT value and adipon-
ectin genotype 
Since it has been suggested that insulin resistance has an 
important role in etiology of type 2 DM and CVD, the effect 
of adiponectin polymorphism on CVD risk factors could be 
confounded by insulin resistance. To explain the effect of insulin 
resistance, the subjects were divided into two groups based on 
KITT  value, and the effect of adiponectin polymorphism on 
hematological variables were analyzed (Table 4); the subjects 
of KITT below 2%/min were grouped as Insulin Resistant group 
(IR), and the subjects of KITT over 2%/min were grouped as Non 
Insulin Resistant group (NIR). Because the subject number was 
limited, groups could not be subdivided according to gender.
Plasma concentrations of fasting blood glucose, hemoglobin 
A1c, insulin, triglyceride, apoB/apoA-1 ratio, TNF-α and IL-6 
were significantly higher in IR group than in NIR group (p<0.05), 
and no differences were found in total cholesterol, LDL-choles-
terol, CRP, leptin and adiponectin level between IR and NIR 
group.
In IR group, mean concentrations of adioponectin and HDL- 
cholesterol were significantly lower, and triglyceride level was 
significantly higher in subjects with T/T genotype than the other 
two genotypes (p<0.05). In NIR group, the subjects with T/T 
genotype showed significantly higher insulin resistance and 
hemoglobin A1c level and significantly lower adiponectin con-
centration than the subjects with other two genotypes 
Adiponectin concentration according to adiponectin genotype 
and CVD risk factors 
To identify if the effect of adiponectin genotype on adiponectin 
concentration is shifted by other CVD risk factors, the subjects 
were divided into high and low subgroups based on the median 
values of BMI, fasting blood glucose, triglyceride, and TNF-α. 
Mean concentrations of adiponectin were compared according 
to the adiponectin genotype in each subgroup (Figure 2). In the 
high BMI, fasting blood glucose, triglyceride, and TNF-α subg-
roups, the subjects with T/T genotype showed significantly lower 
adiponectin concentration than other genotypes (p<0.05). How-
ever, in low subgroups, no significant differences were found 
in adiponectin concentration among three genotypes. 368 Adiponectin gene SNP 276G→T and CVD risk
Table 5. The Pearson’s partial correlation coefficients between nutrient intakes and anthropometric and hematological factors according to adiponectin SNP 276G→T
G/G (n=167)  G/T (n=152)  T/T (n=32) 
Carbohy
drate(g)  Protein(g) Lipid(g)  Carbohy
drate(g)  Protein(g) Lipid(g)  Carbohy
drate(g)  Protein(g) Lipid(g) 
Weight(kg)  0.112  -0.293***  -0.092 0.085 -0.011 -0.069 -0.082 0.174 0.208 
BMI(kg/m
2)  0.153 -0.276**  -0.096 0.196* -0.106 -0.134 -0.106 -0.095 0.006 
Waist(cm)  0.118  -0.252**  -0.099 0.152 -0.086 -0.123 0.033 0.052 0.054 
WHR  0.121 -0.249**  -0.070 0.209* -0.179 -0.148 0.157 -0.095 -0.132 
Fat  mass(kg)  0.143  -0.289***  -0.085 0.147 -0.101 -0.104 0.028 0.174 -0.004 
FBS(mg/dl)  0.019 -0.050 -0.076 -0.095 0.021 0.035 0.133 -0.146 -0.178 
Insulin(ng/dl)  0.173* -0.116 -0.147 0.128 -0.139  -0.207*  -0.232 0.279 0.246 
T-chol(mg/dl)  -0.024 0.007 0.007 0.191* -0.146 -0.123 -0.157 0.131 0.114 
LDL-C(mg/dl)  0.021 0.009 0.013  0.253**  -0.169  -0.157  -0.114 0.109 0.078 
HDL-C(mg/dl)  -0.042  0.058  0.016 -0.259** 0.145 0.247** -0.107 -0.039  0.144 
TG(mg/dl)  -0.100 -0.032 -0.003 0.103 -0.088 -0.155 -0.112 0.174 0.034 
ApoB/apoA-1  0.127 -0.093 -0.145      0.373***  -0.251**  -0.316***  -0.092 0.161 0.011 
CRP(mg/dl)  0.048 -0.149 -0.018 0.126  -0.257**  -0.147 0.151 -0.027 -0.219 
TNF-α(pg/ml)  0.107 -0.183* -0.116 0.172 -0.207* -0.119 -0.111 0.214  0.081 
IL-6(pg/ml)  0.021 -0.098 0.004 0.109 -0.163 -0.089 0.388 -0.289 -0.432 
Leptin(ng/ml)  0.210*  -0.214*  -0.201* 0.139 -0.183 -0.112 -0.393 0.463 0.256 
Adiponectin (μg/ml) -0.135 0.106 0.171 -0.275** 0.212* 0.219* -0.073 -0.039 0.062
Adjusted  for  age,  sex,  and  energy  intake 
*,  **,  ***  ;  significant  by  Pearson’s  partial  correlation  analysis;  p<0.05,  p<0.01  and  p<0.001,  respectively 
Correlation between dietary intakes and anthropometric and 
hematological variables according to adiponectin genotype 
Pearson’s partial correlation analysis was conducted to examine 
the association between macronutrient intakes and anthro-
pometric and hematological variables according to adiponectin 
genotype(Table 5). In G/G genotype, significant negative corr-
elation was shown between protein intake and body weight, BMI, 
waist circumference, body fat mass, abdominal fat thickness, 
TNF-α, and leptin. Carbohydrate intake was positively correlated 
to concentrations of insulin and leptin. In G/T genotype, there 
was positive correlation between carbohydrate intake and values 
of BMI, body fat mass, LDL-cholesterol, and ApoB/apoA-1 ratio, 
and there was negative correlation between carbohydrate intake 
and levels of HDL-cholesterol and adiponectin. Higher protein 
intake was also correlated to lower ApoB/apoA-1 ratio, CRP, 
and leptin in G/T genotype. However, in T/T genotype, there 
was no significant association between macronutrients intakes 
and anthropometric and hematological values (p<0.05).
Discussion 
Adiponectin SNP 276G→T has been reported to be associated 
with serum adiponectin concentration, insulin resistance, and 
CVD risk (Jang et al., 2005; Qi et al., 2006). In the present 
study, the association of SNP 276G→T at adiponectin gene with 
CVD risk factors in Korean type 2 DM patients was studied. 
The prevalence of G/G, G/T, and T/T genotype in our subjects 
were 47.6%, 43.3%, and 9.1%, respectively.
There have been several reports on the distributions of adipon-
ectin gene genotypes among various populations. The prevalence 
of G/G, G/T, and T/T genotype were 50%, 41,7%, 8.3% in 
Korean non-diabetic subjects (Jang et al., 200), 58.3%, 37.0%, 
4.7% in Japanese type 2 DM patients (Hara et al., 2002), 54.7%, 
37.7%, 7.6% in American type 2 DM patients (Qi et al., 2006), 
50.4%, 37.6%, 12% in Italian type 2 DM patients (Bacci et al., 
2004), and 56%, 35.2%, 8.8% in French type 2 DM patients 
(Vasseur  et al., 2002), respectively. The prevalence of G/G 
genotype in our subjects was lower and of G/T genotype was 
higher than Japanese, American and European type 2 DM 
patients, and the prevalence of T/T genotype in our subjects was 
slightly higher than Korean non-diabetic subjects from Jang’s 
study.
The male subjects with T/T genotype showed significantly 
lower adiponectin and HDL-cholesterol levels and higher CRP 
level compared to other two genotypes. These results suggest 
that the homozygotes of +276T may be associated with increased 
CVD risk in Korean type 2 DM patients. When the subjects were 
divided into high and low subgroups based on the median values 
of BMI, fasting blood glucose, triglyceride, and TNF-α, the 
association of T/T genotype with decreased serum adiponectin 
level was observed only in the subgroup with higher values (risk 
groups), not in subgroups with lower values. These results represent 
that the association between adiponectin genotype and serum 
adiponectin level may be stronger in the subjects with high CVD risk.
The association between adiponectin SNP +276 and serum 
adiponectin level, insulin resistance, and CVD risk is cont-
roversial. Filippi et al. (2005) reported that adiponectin SNP So Young Yu et al. 369
276G→T was associated with significantly higher insulin 
resistance and CVD risk in Italian type 2 DM patients, and in 
French (Vasseur et al., 2002) and Swiss non-diabetic subjects 
(Menzaghi  et al., 2002) adiponectin SNP 276G→T was asso-
ciated with decreased concentration of serum adiponectin. On 
the contrary, Lacquemant et al. (2004) reported that adiponectin 
SNP +276 was not associated with CVD in French and Caucasian 
type 2 DM patients. Lee et al. (2003) presented that adiponectin 
SNP +276 did not have effect on insulin resistance and serum 
adiponectin concentration. However, in Japanese type 2 DM 
patients, T/T genotype showed low insulin resistance, and the 
serum concentration of adiponectin was higher in obese subjects 
with T/T genotype than other two genotypes (Hara et al., 2002). 
In Korean non-diabetic subjects, obese subjects with T/T 
genotype also showed lower insulin resistance and higher level 
of adiponectin than other genotypes (Jang et al., 200). It is hard 
to draw a conclusion on the effect of adiponectin SNP +276 
on serum adiponectin level, insulin resistance, and CVD risk at 
present time. Differences in race, gender and disease status should 
be taken into account.
The results of correlation analysis between macronutrient 
intakes and anthropometric and hematological variables were 
different according to adiponectin genotypes. In G/G genotype, 
the negative correlation between protein intake and anthro-
pometric variables was significant. In G/T genotype, carbohy-
drate intake was significantly associated with obesity parameters 
and lipid profiles; however, protein intake was not significantly 
associated with them. In T/T genotype, there was no significant 
association between macronutrient intakes and anthropometric 
and hematological parameters. These results imply that different 
dietary management regime based on adiponectin genotype could 
be helpful for preventing CVD complications in Korean type 2 
DM patients; however, the number of subjects in each genotype 
was too small to draw a clear conclusion for dietary guidelines.
There is a limitation in the current study. Mean duration of 
type 2 DM of subjects in this study was 8 years. Accordingly, 
the medical characteristics of the subjects would be affected by 
medication usage and practice of diet therapy, even though no 
significant differences were found in medication usage and type 
2 DM duration among adiponectin genotypes. 
In summary, CVD risk would be high in type 2 DM patients 
with T/T genotype and the relation of anthropometric and 
hematologic factors to macronutrient intakes was different among 
the three adiponectin genotypes. These results imply that different 
dietary management regime based on adiponectin genotype could 
be helpful for preventing CVD complications in Korean type 2 
DM patients.
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